Psoriasis Clinical Trial

Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment

Summary

The purpose of this observational study is to identify and weight the treatment attributes from the moderate-to-severe Psoriasis (PsO) patients' perspective in Japan.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of moderate-to-severe Psoriasis (PsO) by physician (phase 1) or self-reported (phase 2)
Currently taking systemic psoriasis treatment
Japanese resident aged 20 years and older

Exclusion Criteria:

Unable or unwilling to provide informed consent
Diagnosis of guttate, inverse, pustular, erythrodermic, or drug-induced psoriasis

Study is for people with:

Psoriasis

Estimated Enrollment:

232

Study ID:

NCT05065762

Recruitment Status:

Completed

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Local Institution
Morrisville North Carolina, 27560, United States

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Estimated Enrollment:

232

Study ID:

NCT05065762

Recruitment Status:

Completed

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider